目前对心力衰竭的治疗方法是使用保存的喷射部分
Mauro Riccardi1,2, Emilia D'Elia3, Carlo M Lombardi1,2
1Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25121 Brescia, Italy.
Journal of clinical medicine
|August 14, 2025
概括
包括SGLT2抑制剂和MRA在内的新药疗法正在通过保留喷射分数 (HFpEF) 管理来改变心力衰竭. 早期,个性化的治疗策略是改善HFpEF患者治疗结果的关键.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭是一种复杂的疾病,患病率不断上升,对健康有重大影响.
- 由于最近的治疗进展,目前HFpEF的管理正在发展.
研究的目的:
- 审查HFpEF管理中药物治疗的最新证据.
- 要突出个性化和并发症向治疗策略HFpEF.
主要方法:
- 对HFpEF关键药物类别的当前证据的文献综述.
- 对治疗方法的分析,包括早期启动和表型定制.
主要成果:
- -葡萄糖共运输体2抑制剂 (SGLT2i) 在HFpEF中表现有前途.
- 非类固醇矿物质皮质类受体对抗剂 (MRA) 和类似葡萄糖类-1受体对抗剂 (GLP-1RA) 提供治疗效益.
- ангиотензин受体-neprilysin抑制剂 (RNAI) 有一个选择性的作用.
结论:
- 一个新的指导方针导向,个性化的HFpEF护理时代正在出现.
- 早期干预疾病修饰疗法至关重要.
- 根据患者的表型和并发症,特别是肥胖和糖尿病,量身定制治疗改善了结果.
相关概念视频
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
508
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
508
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K


